Benito-León J - Search Results

1

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases.

Mayo S, Benito-León J, Peña-Bautista C, Baquero M, Cháfer-Pericás C. Mayo S, et al. Curr Neuropharmacol. 2021;19(8):1273-1303. doi: 10.2174/1570159X19666201223154009. Curr Neuropharmacol. 2021. PMID: 33357195 Free PMC article. Review.

2

Candidate Genes for Eyelid Myoclonia with Absences, Review of the Literature.

Mayo S, Gómez-Manjón I, Fernández-Martínez FJ, Camacho A, Martínez F, Benito-León J. Mayo S, et al. Int J Mol Sci. 2021 May 25;22(11):5609. doi: 10.3390/ijms22115609. Int J Mol Sci. 2021. PMID: 34070602 Free PMC article. Review.

3

CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy.

Mayo S, Gómez-Manjón I, Fernández-Martínez FJ, Camacho A, Martínez F, Benito-León J. Mayo S, et al. Int J Mol Sci. 2022 Apr 28;23(9):4879. doi: 10.3390/ijms23094879. Int J Mol Sci. 2022. PMID: 35563270 Free PMC article. Review.

4

Congenital myasthenia syndrome with demyelinating sensorimotor neuropathy responsive to salbutamol monotherapy: a novel clinical phenotype of CHRNE mutation.

Ghosh R, Dubey S, Roy D, Mayo S, Benito-León J. Ghosh R, et al. Among authors: benito leon j. Neurol Sci. 2024 Feb 27. doi: 10.1007/s10072-024-07420-z. Online ahead of print. Neurol Sci. 2024. PMID: 38411853 No abstract available.

5

Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.

Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F. Moreno-Ramos T, et al. J Alzheimers Dis. 2013;34(3):659-64. doi: 10.3233/JAD-121975. J Alzheimers Dis. 2013. PMID: 23271313

6

Viral hepatitis and the risk of Parkinson disease.

Benito-León J. Benito-León J. Neurology. 2017 Apr 25;88(17):1596-1597. doi: 10.1212/WNL.0000000000003853. Epub 2017 Mar 29. Neurology. 2017. PMID: 28356459 No abstract available.

7

Non-steroidal Anti-inflammatory Drugs as Candidates for the Prevention or Treatment of Alzheimer's Disease: Do they Still Have a Role?

Villarejo-Galende A, González-Sánchez M, Blanco-Palmero VA, Llamas-Velasco S, Benito-León J. Villarejo-Galende A, et al. Curr Alzheimer Res. 2020;17(11):1013-1022. doi: 10.2174/1567205017666201127163018. Curr Alzheimer Res. 2020. PMID: 33245273 Review.

8

Premotor cognitive status in a cohort of incident Parkinson disease patients (NEDICES).

Sánchez-Ferro Á, Benito-León J, Mitchell AJ, Louis ED, Posada IJ, Trincado R, Villarejo A, Bermejo-Pareja F. Sánchez-Ferro Á, et al. J Neurol Sci. 2011 Nov 15;310(1-2):211-5. doi: 10.1016/j.jns.2011.05.007. Epub 2011 May 28. J Neurol Sci. 2011. PMID: 21621225

9

Essential tremor is a risk factor for Parkinson's disease.

Louis ED, Benito-Leon J, Faust PL. Louis ED, et al. Parkinsonism Relat Disord. 2016 Mar;24:143-4. doi: 10.1016/j.parkreldis.2016.01.009. Epub 2016 Jan 11. Parkinsonism Relat Disord. 2016. PMID: 26778472 No abstract available.

10

Essential tremor seems to be a risk factor for Parkinson's disease.

Louis ED, Benito-Leon J, Faust PL. Louis ED, et al. Parkinsonism Relat Disord. 2016 May;26:82-3. doi: 10.1016/j.parkreldis.2016.02.026. Epub 2016 Mar 4. Parkinsonism Relat Disord. 2016. PMID: 26972525 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

523 results

Search Page